Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Delay between clinical presentation and treatment of deep venous thrombosis in the lower limbs and regression of thrombosis

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F22%3A10157808" target="_blank" >RIV/00098892:_____/22:10157808 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://journals.sagepub.com/doi/10.1177/02683555211030725" target="_blank" >https://journals.sagepub.com/doi/10.1177/02683555211030725</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1177/02683555211030725" target="_blank" >10.1177/02683555211030725</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Delay between clinical presentation and treatment of deep venous thrombosis in the lower limbs and regression of thrombosis

  • Popis výsledku v původním jazyce

    Introduction: The objective was to investigate the delay between the onset of DVT symptoms and start of anticoagulation in common practice, assess whether this has any impact on the recanalization of venous thrombosis over one year follow up. Methods: A prospective observational study on 76 consecutive patients (39 men, 51.3%) with DVT diagnosed using compression ultrasound (CUS). Timing was classified as very early treatment ≤ 72 hours, early treatment < 7 days and late treatment ≥ 7 days from onset of symptoms. Further development of the disease was monitored by CUS in scheduled visits 1, 3, 6 and 12 months after the start of treatment. Results: Mean delay from symptom onset to the start of anticoagulation was 11.1 days (median 7 days, range 1-42 days) with significant difference (p<0.05) between proximal (12.9 days, median 30 days) and distal DVT (6.5 days, median 2 days). In less than 25% of all patients, with both proximal and distal DVT, treatment was started very early (≤ 72 hours), 40 patients (52.6%) received late treatment ≥ 7 days. There was a positive correlation between delay, average time of complete recanalization (≤ 72 hours 4.2 months, ≥ 7 days 5.3 months, p<0.05) and rate of incomplete recanalization (≤ 72 hours 7.3%, ≥ 7 days 30.9%, p<0.01) in proximal DVT, not in distal DVT. Conclusions: There was a delay of ≥ 7 days in treating in more than half of our patients. The mean interval between clinical onset and start of treatment was significantly shorter and a delay ≥ 7 days significantly less frequent in patients with distal DVT compared to patients with proximal DVT. A very significant positive correlation between delay in treatment and rate of incomplete recanalization of proximal and distal thrombosis indicates that delayed anticoagulation could be a signal risk factor for the incomplete recanalization and development of PTS.

  • Název v anglickém jazyce

    Delay between clinical presentation and treatment of deep venous thrombosis in the lower limbs and regression of thrombosis

  • Popis výsledku anglicky

    Introduction: The objective was to investigate the delay between the onset of DVT symptoms and start of anticoagulation in common practice, assess whether this has any impact on the recanalization of venous thrombosis over one year follow up. Methods: A prospective observational study on 76 consecutive patients (39 men, 51.3%) with DVT diagnosed using compression ultrasound (CUS). Timing was classified as very early treatment ≤ 72 hours, early treatment < 7 days and late treatment ≥ 7 days from onset of symptoms. Further development of the disease was monitored by CUS in scheduled visits 1, 3, 6 and 12 months after the start of treatment. Results: Mean delay from symptom onset to the start of anticoagulation was 11.1 days (median 7 days, range 1-42 days) with significant difference (p<0.05) between proximal (12.9 days, median 30 days) and distal DVT (6.5 days, median 2 days). In less than 25% of all patients, with both proximal and distal DVT, treatment was started very early (≤ 72 hours), 40 patients (52.6%) received late treatment ≥ 7 days. There was a positive correlation between delay, average time of complete recanalization (≤ 72 hours 4.2 months, ≥ 7 days 5.3 months, p<0.05) and rate of incomplete recanalization (≤ 72 hours 7.3%, ≥ 7 days 30.9%, p<0.01) in proximal DVT, not in distal DVT. Conclusions: There was a delay of ≥ 7 days in treating in more than half of our patients. The mean interval between clinical onset and start of treatment was significantly shorter and a delay ≥ 7 days significantly less frequent in patients with distal DVT compared to patients with proximal DVT. A very significant positive correlation between delay in treatment and rate of incomplete recanalization of proximal and distal thrombosis indicates that delayed anticoagulation could be a signal risk factor for the incomplete recanalization and development of PTS.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30201 - Cardiac and Cardiovascular systems

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2022

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    PHLEBOLOGY

  • ISSN

    0268-3555

  • e-ISSN

    1758-1125

  • Svazek periodika

    37

  • Číslo periodika v rámci svazku

    2

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    5

  • Strana od-do

    120-124

  • Kód UT WoS článku

    000679153800001

  • EID výsledku v databázi Scopus

    2-s2.0-85111545991